Search results

I can’t drink coffee, even a few sips give me abdominal pain, diarrhea etc.; but I can eat a little (10 grams?) dark chocolate (above 85% cocoa, the ones that don’t contain any dairy) every day. If I try to increase this amount, I get intestinal symptoms. I am curious if other Crohn’s patients...

https://crohnsmapvaccine.com/ibd-research-lancaster-university/

https://crohnsmapvaccine.com/obituary-professor-john-hermon-taylor/

https://crohnsmapvaccine.com/first-crohns-patient-receives-crohns-map-vaccine/

https://crohnsmapvaccine.com/first-crohns-patient-receives-crohns-map-vaccine/

Food Additive Emulsifiers and Their Impact on Gut Microbiome, Permeability, and Inflammation: Mechanistic Insights in Inflammatory Bowel Disease Aaron S Bancil, Alicia M Sandall, Megan Rossi, Benoit Chassaing, James O Lindsay, Kevin Whelan Journal of Crohn's and Colitis, Volume 15, Issue 6...

Aliment Pharmacol Ther 2020 Jun;51(11):1031-1038. doi: 10.1111/apt.15719.Epub 2020 Apr 24. Efficacy and safety of simultaneous treatment with two biologic medications in refractory Crohn's disease Edward Yang 1, Nicola Panaccione 2, Natalie Whitmire 1, Parambir S Dulai 1, Niels Vande Casteele 1...

https://crohnsmapvaccine.com/crohns-map-vaccine-booster-shot-proven-safe/

https://crohnsmapvaccine.com/q-vaccinologist-dr-tom-merritt-viral-vector-vaccines-including-current-covid-vaccine-astra-zeneca/

https://crohnsmapvaccine.com/our-march-newsletter-is-out/

Anti-MAP Triple Therapy Supports Immunomodulatory http://www.crohnsmapvaccine.com/anti-map-triple-therapy-supports-immunomodulatory-therapeutic-response-crohns-disease-downregulation-nf-κb-activation-absence-map-detection/

Putting Crohn's on the MAP: Five Common Questions on the Contribution of Mycobacterium avium subspecies paratuberculosis to the Pathophysiology of Crohn's Disease Gaurav Agrawal 1 2, John Aitken 3, Harrison Hamblin 4, Michael Collins 5, Thomas J Borody 4 Abstract For decades, Mycobacterium...

Mitochondrial impairment drives intestinal stem cell transition into dysfunctional Paneth cells predicting Crohn’s disease recurrence Sevana Khaloian1, Eva Rath1, Nassim Hammoudi2, Elisabeth Gleisinger1, Andreas Blutke3, Pieter Giesbertz4, Emanuel Berger1, Amira Metwaly1, Nadine Waldschmitt1...

Thomas Joshua Pasvol1, Laura Horsfall1, Stuart Bloom2, Anthony Walter Segal3, Caroline Sabin4,5, Nigel Field4,6, Greta Rait1,5 Received 27 December 2019 Revised 20 May 2020 Accepted 05 June 2020 Abstract Objectives We describe temporal trends in the recorded incidence of inflammatory bowel...

I agree, that’s why I asked for citations. Providing evidence for your claims is fundamental for making discussions and inquiries meaningful. A person can make whatever claims he wants in his own blog, when he is “writing for himself”; but when communicating in a forum, i.e. within a community...

Instead of providing relevant citations as evidence for your claims for the members of this community that follow the thread and communicate in it, posting a link with a bunch of articles and saying read all of them is disrespectful for the community. Is this how you contribute? By making a lot...

So the differentiation between non-pathogenic E Coli species and AIEC is made ex post facto, by looking at the behavioural patterns of the bacteria in the presence of the host’s cells? Could you cite some of the key studies that show, “consistently”, “AIEC sticking to the intestinal lining...

What do you mean by these, specifically? I know only Natalizumab, which was notorious for its increasing the risk of JC virus infections. Do you know of any other in this class that is in development, promising, and safer for Crohn’s disease?

kiny, are you a native speaker of French? Do you follow closely the work at the The Institut Pasteur regarding phages and AIEC? Do you know what they have been doing for the last two years in this area? Some papers and reports: https://www.nature.com/articles/s41385-019-0250-5...

Relevant, from Segal. https://pubmed.ncbi.nlm.nih.gov/31136040/